| Glucokinase and IRS-2 are required for compensatory β cell hyperplasia in response to high-fat diet–induced insulin resistance Y Terauchi, I Takamoto, N Kubota, J Matsui, R Suzuki, K Komeda, A Hara, ... The Journal of clinical investigation 117 (1), 246-257, 2007 | 397 | 2007 |
| Lessons from mouse models of high-fat diet-induced NAFLD A Nakamura, Y Terauchi International journal of molecular sciences 14 (11), 21240-21257, 2013 | 205 | 2013 |
| Relationship between urinary sodium excretion and pioglitazone‐induced edema A Nakamura, T Osonoi, Y Terauchi Journal of diabetes investigation 1 (5), 208-211, 2010 | 170 | 2010 |
| HLA-DQB1* 03: 01 as a biomarker for genetic susceptibility to bullous pemphigoid induced by DPP-4 inhibitors H Ujiie, K Muramatsu, T Mushiroda, T Ozeki, H Miyoshi, H Iwata, ... The Journal of investigative dermatology 138 (5), 1201-1204, 2018 | 119 | 2018 |
| Present status of clinical deployment of glucokinase activators A Nakamura, Y Terauchi Journal of diabetes investigation 6 (2), 124-132, 2015 | 102 | 2015 |
| Amelioration of fatty liver index in patients with type 2 diabetes on ipragliflozin: an association with glucose-lowering effects T Takase, A Nakamura, H Miyoshi, C Yamamoto, T Atsumi Endocrine journal 64 (3), 363-367, 2017 | 89 | 2017 |
| Impact of small-molecule glucokinase activator on glucose metabolism and β-cell mass A Nakamura, Y Terauchi, S Ohyama, J Kubota, H Shimazaki, T Nambu, ... Endocrinology 150 (3), 1147-1154, 2009 | 78 | 2009 |
| Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice K Tajima, A Nakamura, J Shirakawa, Y Togashi, K Orime, K Sato, H Inoue, ... American Journal of Physiology-Endocrinology and Metabolism 305 (8), E987-E998, 2013 | 69 | 2013 |
| Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet T Muraoka, K Aoki, T Iwasaki, K Shinoda, A Nakamura, H Aburatani, ... Metabolism 60 (5), 617-628, 2011 | 66 | 2011 |
| Ipragliflozin effectively reduced visceral fat in Japanese patients with type 2 diabetes under adequate diet therapy C Yamamoto, H Miyoshi, K Ono, H Sugawara, R Kameda, M Ichiyama, ... Endocrine journal 63 (6), 589-596, 2016 | 63 | 2016 |
| Protection from non-alcoholic steatohepatitis and liver tumourigenesis in high fat-fed insulin receptor substrate-1-knockout mice despite insulin resistance A Nakamura, K Tajima, K Zolzaya, K Sato, R Inoue, M Yoneda, K Fujita, ... Diabetologia 55, 3382-3391, 2012 | 50 | 2012 |
| Circulating neutrophil extracellular trap levels in well-controlled type 2 diabetes and pathway involved in their formation induced by high-dose glucose A Miyoshi, M Yamada, H Shida, D Nakazawa, Y Kusunoki, A Nakamura, ... Pathobiology 83 (5), 243-251, 2016 | 49 | 2016 |
| Comparative study of sitagliptin with pioglitazone in Japanese type 2 diabetic patients: the COMPASS randomized controlled trial M Takihata, A Nakamura, K Tajima, T Inazumi, Y Komatsu, H Tamura, ... Diabetes, Obesity and Metabolism 15 (5), 455-462, 2013 | 48 | 2013 |
| Control of beta cell function and proliferation in mice stimulated by small-molecule glucokinase activator under various conditions A Nakamura, Y Togashi, K Orime, K Sato, J Shirakawa, M Ohsugi, ... Diabetologia 55, 1745-1754, 2012 | 47 | 2012 |
| Hyponatremia can be a powerful predictor of the development of isolated ACTH deficiency associated with nivolumab treatment KY Cho, H Miyoshi, A Nakamura, T Kurita, T Atsumi Endocrine Journal 64 (2), 235-236, 2017 | 42 | 2017 |
| A randomized controlled trial comparing the effects of dapagliflozin and DPP-4 inhibitors on glucose variability and metabolic parameters in patients with type 2 diabetes … H Nomoto, H Miyoshi, H Sugawara, K Ono, S Yanagiya, M Oita, ... Diabetology & Metabolic Syndrome 9, 1-9, 2017 | 41 | 2017 |
| Tenofovir–disoproxil–fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infection K Suzuki, G Suda, Y Yamamoto, K Furuya, M Baba, A Nakamura, ... Journal of Gastroenterology 56, 168-180, 2021 | 40 | 2021 |
| Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: a randomized controlled trial T Takase, A Nakamura, C Yamamoto, H Nomoto, A Miya, M Dannoura, ... Journal of Diabetes Investigation 10 (3), 699-705, 2019 | 40 | 2019 |
| Trefoil factor 2 promotes cell proliferation in pancreatic β-cells through CXCR-4-mediated ERK1/2 phosphorylation K Orime, J Shirakawa, Y Togashi, K Tajima, H Inoue, Y Ito, K Sato, ... Endocrinology 154 (1), 54-64, 2013 | 38 | 2013 |
| Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis N Kawagishi, G Suda, A Nakamura, M Kimura, O Maehara, K Suzuki, ... PLoS One 13 (12), e0209615, 2018 | 37 | 2018 |
